111787-93-0

Basic information

• Product Name: 3-Furanmethanol, 5-(4-fluorophenyl)-2-methyl-
• CAS NO: 111787-93-0
• Molecular Formula: C12H11FO2
• Molecular Weight: 206.217
• Mol File: 111787-93-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-Furanmethanol, 5-(4-fluorophenyl)-2-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Furanmethanol, 5-(4-fluorophenyl)-2-methyl-(111787-93-0)
• EPA Substance Registry System: 3-Furanmethanol, 5-(4-fluorophenyl)-2-methyl-(111787-93-0)

Safety Data

• Hazardous Substances Data: 111787-93-0(Hazardous Substances Data)

Upstream product

• 444914-29-8 methyl 5-(4-fluorophenyl)-2-methylfuran-3-carboxylate 
• 36967-50-7 ethyl 2-acetyl-4-(4-fluorophenyl)-4-oxobutanoate 
• 403-29-2 2-bromo-4'-fluoroacetophenone 
• 111787-83-8 ethyl 5-(4-fluorophenyl)-2-methylfuran-3-carboxylate 

Relevant articles and documents

FURAN OR THIOPHENE DERIVATIVE AND MEDICINAL USE THEREOF

The present invention provides a compound represented by the formula (I): [wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, p is 0, 1 or 2, and when p is 2, each R may be the same or different, R1 is a hydrogen atom or an optionally substituted hydrocarbon group, R2 is an optionally substituted aromatic group, Ring A is an optionally substituted monocyclic aromatic ring or optionally substituted bicyclic aromatic fused ring, X1 is an oxygen atom or a sulfur atom, X2 is a bond, an oxygen atom or -S(O)n- (wherein n is 0, 1 or 2), Y is a bond, an oxygen atom, -S(O)m-, -C(=O)-N(R3)- or -N(R3)-C(=O)- (R3 is a hydrogen atom, an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, and m is 0, 1 or 2), M1, M2 and M3 may be the same or different and are each independently a bond or an optionally substituted divalent aliphatic hydrocarbon group, and M4 is an optionally substituted divalent aliphatic hydrocarbon group] or a salt thereof, which is useful as a prophylactic and/or therapeutic agent for lipid metabolism abnormality, arteriosclerotic disease and sequelae thereof, diabetes mellitus and the like.